Empire Blue – Medical Policy and Clinical Guideline Updates
August 5, 2022Aug 1, 2022 • Policy Updates / Medical Policy & Clinical Guidelines
Includes:
Revised medical policies effective June 29, 2022
The following policies were updated with new CPT®/HCPCS/ICD-10-PCS procedure code and/or ICD-10-CM diagnosis code updates:
- 00049 Circulating Tumor DNA Panel Testing (Liquid Biopsy)
- 00052 Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling
- 00056 Gene Expression Profiling for Bladder Cancer
- 00003 In Vitro Chemosensitivity Assays and In Vitro Chemoresistance Assays
- 00019 Proprietary Algorithms for Liver Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease
Source: https://providernews.empireblue.com/article/medical-policy-and-clinical-guideline-updates-12